RETRACTION: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment (vol 89, pg 761, 2022) (Retraction of Vol 89, Pg 761, 2022)

被引：0

作者：

Oya, Mototsugu ^{[1
]}

Kaneko, Shuichi ^{[2
]}

Imai, Tsuneo ^{[3
]}

Tsujino, Toshiaki ^{[4
]}

Sunaya, Toshiyuki ^{[5
]}

Okayama, Yutaka ^{[4
]}

机构：

[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan

[2] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan

[3] Higashi Nagoya Natl Hosp, Natl Hosp Org, Nagoya, Aichi, Japan

[4] Bayer Yakuhin Ltd, Med Affairs & Pharmacovigilance, 2-4-9 Umeda,Kita Ku, Osaka 5300001, Japan

[5] Bayer Yakuhin Ltd, Prod Dev, Osaka, Japan

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2024年 / 93卷 / 05期

关键词：

D O I：

10.1007/s00280-023-04587-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：523 / 523

页数：1

共 50 条

[1] Retraction Note: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Mototsugu Oya
Shuichi Kaneko
Tsuneo Imai
Toshiaki Tsujino
Toshiyuki Sunaya
Yutaka Okayama
Cancer Chemotherapy and Pharmacology, 2024, 93 : 523 - 523
[2] RETRACTED ARTICLE: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Mototsugu Oya
Shuichi Kaneko
Tsuneo Imai
Toshiaki Tsujino
Toshiyuki Sunaya
Yutaka Okayama
Cancer Chemotherapy and Pharmacology, 2022, 89 : 761 - 772
[3] RETRACTION: The influence of ultraviolet radiations on some rat's tissues (Retraction of Vol 51, Pg 761, 2022)
Fawzy, M. Adel
Yehia, Mona Abdel-Hamed
Elghnam, SamehM.
Mohamed, Eman
Elbashar, Y. H.
JOURNAL OF OPTICS-INDIA, 2024, 53 (02): : 1655 - 1655
[4] RETRACTED: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment (Retracted Article)
Oya, Mototsugu
Kaneko, Shuichi
Imai, Tsuneo
Tsujino, Toshiaki
Sunaya, Toshiyuki
Okayama, Yutaka
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (06) : 761 - 772
[5] RETRACTION: The Application of the Iliac Artery in the Ex Vivo Reconstruction of Renal Arteries in Renal Transplantation (Retraction of Vol 89, Pg 1113, 2010)
Pan, G.
Chen, Z.
Liao, D.
TRANSPLANTATION, 2019, 103 (08) : 1736 - 1736
[6] RETRACTION: MicroRNA-573 functions as a tumor suppressor and is downregulated by PICSAR in cutaneous squamous cell carcinoma (Vol 22, pg 229, 2022) (Retraction of Vol 22, Pg 229, 2022)
Ma, Wendong
Ang, Irene Ling
Lei, Kate M. K.
Lam, Melody Man Ting
Zhang, Pengwei
Poon, Terence Chuen Wai
BIOMOLECULES AND BIOMEDICINE, 2023, 23 (01): : 188 - 188
[7] RETRACTION: Astragalus membranaceus and Salvia miltiorrhiza Ameliorate Hypertensive Renal Damage through lncRNA-mRNA Coexpression Network (vol 2022, pg 14, 2022) (Retraction of Vol 2022, art no 3002353, 2022)
Zhou, L.
Han, C.
Liu, Y.
BIOMED RESEARCH INTERNATIONAL, 2023, 2023
[8] RETRACTION: Immunotherapy of metastatic renal cell carcinoma (Retraction of Vol 115, Pg S2298, 2009)
McDermott, D. F.
CANCER, 2019, 125 (14) : 2514 - 2514
[9] RETRACTION: Corrigendum to Posterior Reversible Encephalopathy Syndrome (Pres) Secondary To Renal Artery Thrombosis Following Covid-19 Vaccination (vol 703, pg 499, 2022) (Retraction of Vol 703, Pg 499, 2022)
Yeung, J. A.
Grain, R.
Koh, C.
Wang, Y. Y.
EUROPEAN STROKE JOURNAL, 2023, 8 (02) : 604 - 604
[10] RETRACTION: Cancer-associated fibroblasts promote renal cell carcinoma progression (Retraction of Vol 36, Pg 3483, 2015)
Stigbrand, Torgny
TUMOR BIOLOGY, 2017,

← 1 2 3 4 5 →